Microangiopathy, Arterial Stiffness, and Risk Stratification in Patients With Type 2 Diabetes-Reply

Affiliations

Comment

Benjamin M Scirica et al. JAMA Cardiol. 2017.

. 2017 Jul 1;2(7):821.

doi: 10.1001/jamacardio.2017.0164.

¹ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.
Scirica BM, Bhatt DL, Braunwald E, Raz I, Cavender MA, Im K, Mosenzon O, Udell JA, Hirshberg B, Pollack PS, Steg PG, Jarolim P, Morrow DA. Scirica BM, et al. JAMA Cardiol. 2016 Dec 1;1(9):989-998. doi: 10.1001/jamacardio.2016.3030. JAMA Cardiol. 2016. PMID: 27681000
Microangiopathy, Arterial Stiffness, and Risk Stratification in Patients With Type 2 Diabetes.
Antonopoulos AS, Siasos G, Tousoulis D. Antonopoulos AS, et al. JAMA Cardiol. 2017 Jul 1;2(7):820-821. doi: 10.1001/jamacardio.2017.0159. JAMA Cardiol. 2017. PMID: 28297006 No abstract available.